CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Founded in 1993, BB Biotech is one of the world’s leading biotech investors. The Swiss company primarily invests in biotechnological firms that operate in various sectors, including oncology, cardiovascular, autoimmune, metabolic and infectious diseases. BB Biotech’s portfolio consists of 20-35 companies, such as Celgene, Incyte, Ionis Pharmaceuticals, Gilead, Vertex Pharmaceuticals, Radius Health, Neurocrine Biosciences, Alexion Pharmaceuticals, Agios Pharmaceuticals, Novo Nordisk, etc. Headquartered in Kusnacht, Switzerland, the BB Biotech share price (BION) is set and traded on the SIX Swiss Exchange, Frankfurt Stock Exchange and Borsa Italiana.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.